LYTIR

Insider · SEC Form 4 · EVP Commercial

Marion McCourt

Filed with the SEC as McCourt Marion; the order above is the one the filer's own signature uses.

In the 12 months to Nov 19, 2026, on the open market: sold $3.5M of REGN. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $3.5M in total.Sep: Insider sales $2.0MOct: Insider sales $984KNov: Insider sales $544KDecJanFebMarAprMayJunJulAugSepOctNov$2.0M
Insider purchases above the line: $0Insider sales below: $3.5M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. REGNSold: REGENERON PHARMACEUTICALS, INC. Nov 16, 2026 566 shares filed Nov 18, 2026 13 transactions 10b5-1 plan filing $544K
  2. REGNSold: REGENERON PHARMACEUTICALS, INC. Oct 30, 2026 1,132 shares filed Nov 3, 2026 10,871 shares held directly after, as filed 10b5-1 plan filing $984K
  3. REGNSold: REGENERON PHARMACEUTICALS, INC. Sep 3, 2026 1,131 shares filed Sep 3, 2026 12,003 shares held directly after, as filed 10b5-1 plan filing $970K
  4. REGNSold: REGENERON PHARMACEUTICALS, INC. Sep 2, 2026 1,215 shares filed Sep 3, 2026 13,134 shares held directly after, as filed 10b5-1 plan filing $1.0M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Planned sales (Form 144)

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice

  1. REGNMcCourt Marion filed Nov 16, 2026 REGENERON PHARMACEUTICALS, INC. Officer 566 shares planned sale date 11/16/2026 filing $545K
  2. REGNMcCourt Marion filed Oct 30, 2026 REGENERON PHARMACEUTICALS, INC. Officer 1,132 shares planned sale date 10/30/2026 filing $984K
  3. REGNMcCourt Marion filed Sep 3, 2026 REGENERON PHARMACEUTICALS, INC. Officer 1,131 shares planned sale date 09/03/2026 filing $969K
  4. REGNMcCourt Marion filed Sep 2, 2026 REGENERON PHARMACEUTICALS, INC. Officer 1,215 shares planned sale date 09/02/2026 filing $1.0M